ロード中...
Facts and new hopes on selective FGFR inhibitors in solid tumors
Precision oncology relies on the identification of molecular alterations, responsible for tumor initiation and growth, that are suitable targets of specific inhibitors. The development of FGFR inhibitors represents an edifying example of the rapid evolution in the field of targeted oncology, with 10...
保存先:
| 出版年: | Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7024606/ https://ncbi.nlm.nih.gov/pubmed/31585937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2035 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|